The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Press Releases

2012
Please select
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
AUG
23
The United Laboratories International Holdings Limited Announces 2012 Interim Results, Turnover Increased to HK$3.65 Billion Prices of Intermediate Products and Bulk Medicine Becomes Stable Overseas Sales Surges 35.7%
JUN
12
Media Reports of TUL Pollution in Wuliangsuhai Fabricated
APR
18
TUL's Capsule Casings in Full Compliance with National Safety Standards
MAR
28
The United Laboratories International Holdings Limited Announces 2011 Annual Results, Achieved Turnover of Approximately HK$6.4 Billion, Prices of Intermediate Products and Bulk Medicine Becomes Stable in 2012, Orders of Human Insulin Increases Gradually
Disclaimer | Sitemap

Copyright © 2019 The United Laboratories International Holdings Limited. All rights reserved.